August 4, 2026
Researchers at the University of Pittsburgh have identified novel molecular pathways that distinguish severe asthma from milder forms of the disease. The findings, published in JCI Insight, open the door to new treatments for the 5–10% of asthma patients who have severe disease that does not respond to current treatments.